TPDB

3D PDB MODEL

Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

TPDB ID TPDB66420

Peptide_Name

ACE inhibitor

Activity

ACE inhibitors

Activity_category_statistics

Cardiometabolic peptides

Database_Source

Peptipedia

Sequence_Type

standard

Has_Modification No

Description A 16-aa standard natural ace inhibitors peptide sequence curated from Peptipedia, with an available 3D structural model.

Sequence

GEHGGAGMGGGQFQPV

FASTA

>TPDB66420|ACE inhibitors|length=16
GEHGGAGMGGGQFQPV

Formula C62H92N20O21S1

Absent Amino Acids RNDCILKSTWY

Common Amino Acids G

Mass 1485.59

PI 5.13

Basic Residues 1

Acidic Residues 1

Hydrophobic Residues 4

Net Charge -1

Boman Index 3.20

Hydrophobicity -0.463

Aliphatic Index 24.38

Half Life

Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour

Extinction Coefficient Cystines 0

Absorbance 280nm 0.00

Polar Residues 2

number

1

A

0

R

0

N

0

D

0

C

1

E

2

Q

7

G

1

H

0

I

0

L

0

K

1

M

1

F

1

P

0

S

0

T

0

W

0

Y

1

V

Amino Acid Distribution

A: 1 R: 0 N: 0 D: 0 C: 0 E: 1 Q: 2 G: 7 H: 1 I: 0 L: 0 K: 0 M: 1 F: 1 P: 1 S: 0 T: 0 W: 0 Y: 0 V: 1

Length

16

Formula

C62H92N20O21S1

Mass

1485.59

PI

5.13

Net Charge

-1

Boman Index

3.20

Hydrophobicity

-0.463

Chemical_Mass

1485.5777

Monoisotopic_Mass

1484.6446

Evidence 1 Activity

Activity

Activity Endpoint IC50

Detail Source Activity ACE inhibitors

Activity Measurement 490.55 µM

Function Inhibitor of Angiotensin-Converting Enzyme (ACE) (EC 3.4.15.1) (MEROPS ID: M02-001)

Detail Activity ACE inhibitor

Activity Code ah

Source & Reference

Database Source NA

Authors Złotek U., Jakubczyk A., Rybczyńska-Tkaczyk K., Ćwiek P., Baraniak B., Lewicki S.

Title

Characteristics of new peptides GQLGEHGGAGMG, GEHGGAGMGGGQFQPV, EQGFLPGPEESGR, RLARAGLAQ, YGNPVGGVGH, and GNPVGGVGHGTTGT as inhibitors of enzymes involved in metabolic syndrome and antimicrobial potential. Molecules, 25, 2492, 2020

Year 2020

Literature Source Journal

Other

Number of Residues 16

Additional Info

BIOPEP-UWM database of bioactive peptides SMILES: NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=C[N]([H])C=N1)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CCC(=O)N)C(=O)N3[C@@H](CCC3)C(=O)N[C@@H](C(C)C)C(=O)O InChI=1S/C62H92N20O21S/c1-32(2)53(62(102)103)81-60(100)42-11-8-19-82(42)61(101)39(13-16-44(65)84)78-59(99)40(21-34-9-6-5-7-10-34)79-57(97)36(12-15-43(64)83)76-50(90)29-69-46(86)25-67-47(87)26-71-55(95)38(18-20-104-4)77-51(91)30-70-54(94)33(3)74-49(89)28-68-48(88)27-72-56(96)41(22-35-24-66-31-73-35)80-58(98)37(14-17-52(92)93)75-45(85)23-63/h5-7,9-10,24,31-33,36-42,53H,8,11-23,25-30,63H2,1-4H3,(H2,64,83)(H2,65,84)(H,66,73)(H,67,87)(H,68,88)(H,69,86)(H,70,94)(H,71,95)(H,72,96)(H,74,89)(H,75,85)(H,76,90)(H,77,91)(H,78,99)(H,79,97)(H,80,98)(H,81,100)(H,92,93)(H,102,103)/t33-,36-,37-,38-,39-,40-,41-,42-,53-/m0/s1 InChIKey=JFKBYXMYUBSVHF-KAWKATIESA-N Inhibitor of Angiotensin-Converting Enzyme (ACE) (EC 3.4.15.1) (MEROPS ID: M02-001) according to the BIOPEP-UWM database of bioactive peptides (ID 9782) Inhibitor of Alpha-amylase (EC 3.2.1.1) according to the BIOPEP-UWM database of bioactive peptides (ID 9783) Inhibitor of pancreatic lipase according to the BIOPEP-UWM database of bioactive peptides (ID 9784) Inhibitor of lipoxygenase (LOX) according to the BIOPEP-UWM database of bioactive peptides (ID 9785) Inhibitor of cyclooxygenase-1 (COX-1) (EC 1.14.99.1) according to the BIOPEP-UWM database of bioactive peptides (ID 9786) Inhibitor of cyclooxygenase-2 (COX-2) (EC 1.14.99.1) according to the BIOPEP-UWM database of bioactive peptides (ID 9787)

Number_of_Residues

16